CHRONIC HEMODIALYSIS PATIENTS

Clinical trials for CHRONIC HEMODIALYSIS PATIENTS explained in plain language.

Never miss a new study

Get alerted when new CHRONIC HEMODIALYSIS PATIENTS trials appear

Sign up with your email to follow new studies for CHRONIC HEMODIALYSIS PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a lower dose of rivaroxaban be safer for kidney patients on dialysis?

Knowledge-focused Recruiting now

This study is testing three different low doses of the blood thinner rivaroxaban in 10 adults on chronic hemodialysis. The goal is to see how the drug behaves in the body and how much it thins the blood, to find a dose that might lower bleeding risks. Participants will take each …

Matched conditions: CHRONIC HEMODIALYSIS PATIENTS

Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Knowledge-focused

Last updated Jun 22, 2026 11:57 UTC

CHRONIC HEMODIALYSIS PATIENTS

Get alerted when new CHRONIC HEMODIALYSIS PATIENTS trials appear

Can a lower dose of rivaroxaban be safer for kidney patients on dialysis?